DOYLESTOWN, PA–(Dec 11, 2014) – ProPhase Labs, Inc. (NASDAQ: PRPH), a company that engages in the manufacture, marketing, and distribution of homeopathic and health products to the general public, announced today that CEO & Chairman Ted William Karkus will be interviewed live by host Michael Yorba on Clear Channel – iHeart Business Talk Radio’s The Traders Network Show. In this exclusive 2-segment interview, Mr. Karkus will discuss the research and development of over-the-counter (OTC) drugs, natural base health products with supplements, personal care and cosmeceutical products. We encourage investors, analysts, industry professionals and all interested parties to tune in and listen live via Clear Channel’s nationally syndicated iHeart Radio stream.
Start Time: 9:30pm ET | 6:30pm PT | 8:30pm CT (U.S.)
Network: Clear Channel – iHeart
Station: DFW 1190AM
KFXR Show: The Trader’s Network
Host: Michael Yorba
Live iHeart Radio Stream:http://www.iheart.com/live/4276/?autoplay=true
About ProPhase Labs, Inc.: ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter (OTC) cold remedy and consumer products, natural base health products, and other supplements and cosmeceuticals in the United States.
Founded in 1989, the Company is headquartered in Doylestown, Pennsylvania. ProPhase Labs’ stock is traded on the NASDAQ Global Market (NASDAQ: PRPH).
Our mission is to develop and market remedies that offer pioneering new options to improve treatment results. We develop and acquire high performance homeopathic and allopathic compounds and offer unique methods to deliver those compounds. Our core objective is to address the root cause of symptoms and conditions with the goal of exceeding the efficacy and safety of current treatment options.
Our ongoing objective is to deliver long-term value to our constituents by providing exceptional new products that address the health care and quality of life concerns of the broadest market segments. Simply put, we utilize cutting-edge science to change lives. For more information visit:http://www.clearstream.tv/
About Clear Channel: Clear Channel’s Media and Entertainment division has the largest reach of any radio or television outlet in America with 243 million monthly listeners. It serves 150 cities through 850 owned radio stations in the U.S., as well as more than 140 stations in New Zealand and Australia. www.clearchannel.com.
About The Traders Network Show: For the past six years “The Traders Network Show” has been hosted and broadcasted live daily on Clear Channel DFW 1190AM KFXR from 6am – 7:30am and 2pm – 3pm CT, Monday-Friday. Host Michael Yorba interviews the front-page Titans about the latest in capital markets, CEO milestones, trading tools, real estate acquisitions and market trends. Learn how the experts use risk management techniques to build fully diversified portfolios and what it takes to put up big board earnings. It’s a fast moving, high-energy show that presents stocks, commodities, bonds, forex, derivatives, real estate, political trends, technology trends, crowd funding and impact investment insights in a new light and keeps audience asking for more… shift your thinking and join us as we deliver “tomorrow’s ideas today” on iHeart Radio and Clear Channel’s The Traders Network Show. To inquire about being a guest on this show please contact “1800pr” at www.1800PublicRelations.com.
Forward Looking Information
Except for the historical information contained herein or discussed on air on December 11, 2014, this document and our on-air discussion contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve a number of risks and uncertainties, including the difficulty of the acceptance and demand for our products, the impact of competitive products and pricing, the timely development and launch of new products, and the risk factors listed from time to time in our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and any subsequent SEC filings.